04.21.25 -- 4 Key Solid Tumor Therapy Objectives iPSCs Can Help Achieve

Discover how TFDF-based perfusion technology boosts lentiviral vector production by over 10-fold, slashes costs, and accelerates the commercialization of CAR-T and other advanced cell therapies.

Traditional fed-batch cell culture processes face limitations due to inherent cell line restrictions and accumulation of byproducts, necessitating new approaches that improve cell performance.

Drug developers must understand the latest trends in microbial fermentation. By leveraging innovative methods and technologies, developers can unlock new opportunities and improve patient outcomes.

The success of this experiment shows how the integration of Process Analytical Technology probes into bioreactors can enhance process understanding and enable precise bioprocess monitoring and control.

Enable a wide array of genomic manipulation with the more regulated and efficient genomic insertion that's made possible by transposase-based technologies.

In this article, the author, an Associate Professor at Universiti Sains Malaysia, shares their positive experience using two specialized benchtop bioreactors to enhance bioprocess education and research.

A high-performance, helper virus-free stable producer cell line is derived from proprietary high-producer HEK293 cells and is cultivated in a chemically defined, serum-free, ADCF medium in suspension.